{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:17:22Z","timestamp":1786119442425,"version":"build-2736575974"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1097\/md.0000000000003734","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T11:07:09Z","timestamp":1464260829000},"page":"e3734","source":"Crossref","is-referenced-by-count":21,"title":["IL-8 Alterations in HIV-1 Infected Children With Disease Progression"],"prefix":"10.1097","volume":"95","author":[{"given":"Ambili Nair","family":"Pananghat","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heena","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somi Sankaran","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzamil Ashraf","family":"Makhdoomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravinder","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Lodha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakir","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maddur","family":"Srinivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bimal Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindra Mohan","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushil Kumar","family":"Kabra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Luthra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-27-20210226","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1530\/ror.0.0030042","article-title":"Host and viral factors influencing heterosexual HIV transmission","volume":"3","author":"Miller","year":"1998","journal-title":"Rev Reprod"},{"key":"R2-27-20210226","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1128\/JVI.01573-14","article-title":"Host genetic and viral determinants of HIV-1 RNA set point among HIV-1 seroconverters from sub-saharan Africa","volume":"89","author":"Mackelprang","year":"2015","journal-title":"J Virol"},{"key":"R3-27-20210226","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1128\/JVI.02118-12","article-title":"Cumulative impact of host and viral factors on HIV-1 viral-load control during early infection","volume":"87","author":"Yue","year":"2013","journal-title":"J Virol"},{"key":"R4-27-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJM199501263320402","article-title":"Studies in subjects with long-term nonprogressive human immunodeficiency virus infection","volume":"332","author":"Pantaleo","year":"1995","journal-title":"N Engl J Med"},{"key":"R5-27-20210226","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1097\/00002030-199309000-00002","article-title":"The characterization of non-progressors: long-term HIV-1 infection with stable CD4+ T-cell levels","volume":"7","author":"Sheppard","year":"1993","journal-title":"AIDS Lond Engl"},{"key":"R6-27-20210226","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1097\/QAI.0b013e31818ce709","article-title":"Early control of HIV-1 infection in long-term nonprogressors followed since diagnosis in the ANRS SEROCO\/HEMOCO cohort","volume":"50","author":"Madec","year":"2009","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"R7-27-20210226","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1086\/646609","article-title":"Clinical outcomes of elite controllers, viremic controllers, and long-term nonprogressors in the US Department of Defense HIV natural history study","volume":"200","author":"Okulicz","year":"2009","journal-title":"J Infect Dis"},{"key":"R8-27-20210226","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1086\/521165","article-title":"Long-term nonprogression of HIV infection in children: evaluation of the ANRS prospective French Pediatric Cohort","volume":"45","author":"Warszawski","year":"2007","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"R9-27-20210226","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/nri3277","article-title":"The impact of differential antiviral immunity in children and adults","volume":"12","author":"Prendergast","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"R10-27-20210226","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1126\/science.273.5283.1856","article-title":"Genetic restriction of HIV-1 infection and progression to AIDS by a deletion allele of the CKR5 structural gene. Hemophilia Growth and Development Study, Multicenter AIDS Cohort Study, Multicenter Hemophilia Cohort Study, San Francisco City Cohort, ALIVE Study","volume":"273","author":"Dean","year":"1996","journal-title":"Science"},{"key":"R11-27-20210226","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.molimm.2014.05.016","article-title":"Gene expression profile in long-term non progressor HIV infected patients: in search of potential resistance factors","volume":"62","author":"Luque","year":"2014","journal-title":"Mol Immunol"},{"key":"R12-27-20210226","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature03113","article-title":"Dominant influence of HLA-B in mediating the potential co-evolution of HIV and HLA","volume":"432","author":"Kiepiela","year":"2004","journal-title":"Nature"},{"key":"R13-27-20210226","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/imr.12074","article-title":"Immunology of pediatric HIV infection","volume":"254","author":"Tobin","year":"2013","journal-title":"Immunol Rev"},{"key":"R14-27-20210226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2047-783X-15-1-1","article-title":"HIV-induced immune activation: pathogenesis and clinical relevance\u2014summary of a workshop organized by the German AIDS Society (DAIG e.v.) and the ICH Hamburg, Hamburg, Germany, November 22, 2008","volume":"15","author":"Stellbrink","year":"2010","journal-title":"Eur J Med Res"},{"key":"R15-27-20210226","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/imr.12079","article-title":"HIV-associated chronic immune activation","volume":"254","author":"Paiardini","year":"2013","journal-title":"Immunol Rev"},{"key":"R16-27-20210226","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/imr.12065","article-title":"Immune activation and HIV persistence: implications for curative approaches to HIV infection","volume":"254","author":"Klatt","year":"2013","journal-title":"Immunol Rev"},{"key":"R18-27-20210226","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"R19-27-20210226","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/QAI.0b013e3181e66216","article-title":"Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort","volume":"55","author":"Tien","year":"2010","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"R20-27-20210226","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1742-6405-4-11","article-title":"Predictors of disease progression in HIV infection: a review","volume":"4","author":"Langford","year":"2007","journal-title":"AIDS Res Ther"},{"key":"R22-27-20210226","doi-asserted-by":"crossref","first-page":"3719","DOI":"10.1128\/JVI.01844-08","article-title":"Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections","volume":"83","author":"Stacey","year":"2009","journal-title":"J Virol"},{"key":"R23-27-20210226","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.cytogfr.2012.05.007","article-title":"The role of cytokines in the pathogenesis and treatment of HIV infection","volume":"23","author":"Catalfamo","year":"2012","journal-title":"Cytokine Growth Factor Rev"},{"key":"R24-27-20210226","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1086\/652749","article-title":"Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection","volume":"201","author":"Neuhaus","year":"2010","journal-title":"J Infect Dis"},{"key":"R25-27-20210226","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/00002030-200209270-00002","article-title":"Limited immune restoration after 3 years\u2019 suppression of HIV-1 replication in patients with moderately advanced disease","volume":"16","author":"Valdez","year":"2002","journal-title":"AIDS Lond Engl"},{"key":"R26-27-20210226","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1590\/S0037-86822012000600002","article-title":"Immunovirological parameters and cytokines in HIV infection","volume":"45","author":"Tasca","year":"2012","journal-title":"Rev Soc Bras Med Trop"},{"key":"R27-27-20210226","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/01.qai.0000437171.00504.41","article-title":"Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202","volume":"65","author":"McComsey","year":"2014","journal-title":"J Acquir Immune Defic Syndr 1999"},{"key":"R28-27-20210226","doi-asserted-by":"crossref","first-page":"e521","DOI":"10.1097\/MD.0000000000000521","article-title":"No differences of immune activation and microbial translocation among HIV-infected children receiving combined antiretroviral therapy or protease inhibitor monotherapy","volume":"94","author":"Falcon-Neyra","year":"2015","journal-title":"Medicine (Baltimore"},{"key":"R29-27-20210226","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3851\/IMP1530","article-title":"Proteomic analysis identifies prohibitin down-regulation as a crucial event in the mitochondrial damage observed in HIV-infected patients","volume":"15","author":"Ciccosanti","year":"2010","journal-title":"Antivir Ther"},{"key":"R30-27-20210226","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/092986711794088371","article-title":"The toxicogenetics of antiretroviral therapy: the evil inside","volume":"18","author":"Gutierrez","year":"2011","journal-title":"Curr Med Chem"},{"key":"R31-27-20210226","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1001\/jama.284.2.215","article-title":"Current evidence and future directions for targeting HIV entry: therapeutic and prophylactic strategies","volume":"284","author":"Souza","year":"2000","journal-title":"JAMA"},{"key":"R32-27-20210226","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/JVI.75.17.8195-8202.2001","article-title":"Interleukin-8 stimulates human immunodeficiency virus type 1 replication and is a potential new target for antiretroviral therapy","volume":"75","author":"Lane","year":"2001","journal-title":"J Virol"},{"key":"R33-27-20210226","doi-asserted-by":"crossref","first-page":"590","DOI":"10.3390\/v7020590","article-title":"Mutations in the reverse transcriptase and protease genes of human immunodeficiency virus-1 from antiretroviral na\u00efve and treated pediatric patients","volume":"7","author":"Bure","year":"2015","journal-title":"Viruses"},{"key":"R34-27-20210226","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1126\/science.271.5247.324","article-title":"Toward an understanding of the correlates of protective immunity to HIV infection","volume":"271","author":"Haynes","year":"1996","journal-title":"Science"},{"key":"R35-27-20210226","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1089\/088922299309784","article-title":"Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy","volume":"15","author":"Imami","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R36-27-20210226","doi-asserted-by":"crossref","first-page":"e0131922","DOI":"10.1371\/journal.pone.0131922","article-title":"Immunologic and virologic progression in HIV controllers: the role of viral \u201cblips\u201d and immune activation in the ANRS CO21 CODEX Study","volume":"10","author":"Noel","year":"2015","journal-title":"PloS One"},{"key":"R37-27-20210226","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1126\/science.8235617","article-title":"Multifactorial nature of human immunodeficiency virus disease: implications for therapy","volume":"262","author":"Fauci","year":"1993","journal-title":"Science"},{"key":"R38-27-20210226","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1093\/infdis\/175.1.47","article-title":"Cytokine pattern in relation to disease progression in human immunodeficiency virus-infected children","volume":"175","author":"Than","year":"1997","journal-title":"J Infect Dis"},{"key":"R39-27-20210226","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJM199503023320904","article-title":"Increases in CD4 T lymphocytes with intermittent courses of interleukin-2 in patients with human immunodeficiency virus infection. A preliminary study","volume":"332","author":"Kovacs","year":"1995","journal-title":"N Engl J Med"},{"key":"R40-27-20210226","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1126\/science.7903123","article-title":"Restoration of HIV-specific cell-mediated immune responses by interleukin-12 in vitro","volume":"262","author":"Clerici","year":"1993","journal-title":"Science"},{"key":"R41-27-20210226","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/aid.1992.8.191","article-title":"The effect of cytokines and pharmacologic agents on chronic HIV infection","volume":"8","author":"Poli","year":"1992","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R42-27-20210226","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1128\/CVI.00565-15","article-title":"Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination","volume":"23","author":"Martinez","year":"2015","journal-title":"Clin Vaccine Immunol CVI"},{"key":"R43-27-20210226","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00002030-199207000-00018","article-title":"CD4 lymphocyte depletion prior to the development of AIDS","volume":"6","author":"Phillips","year":"1992","journal-title":"AIDS Lond Engl"},{"key":"R44-27-20210226","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/00126334-199208000-00005","article-title":"Effect of CD4+ cell count measurement variability on staging HIV-1 infection","volume":"5","author":"Hoover","year":"1992","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R45-27-20210226","doi-asserted-by":"crossref","first-page":"946","DOI":"10.7326\/0003-4819-126-12-199706150-00003","article-title":"Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection","volume":"126","author":"Mellors","year":"1997","journal-title":"Ann Intern Med"},{"key":"R48-27-20210226","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0014-5793(92)80909-Z","article-title":"Interleukin-8, a chemotactic and inflammatory cytokine","volume":"307","author":"Baggiolini","year":"1992","journal-title":"FEBS Lett"},{"key":"R49-27-20210226","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1172\/JCI118625","article-title":"T lymphocyte recruitment by interleukin-8 (IL-8). IL-8-induced degranulation of neutrophils releases potent chemoattractants for human T lymphocytes both in vitro and in vivo","volume":"97","author":"Taub","year":"1996","journal-title":"J Clin Invest"},{"key":"R50-27-20210226","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.4049\/jimmunol.160.6.2872","article-title":"Superinduction of IL-8 in T cells by HIV-1 Tat protein is mediated through NF-kappaB factors","volume":"160","author":"Ott","year":"19501998","journal-title":"J Immunol (Baltim Md"},{"key":"R51-27-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.1993.tb07957.x","article-title":"Elevated serum levels of IL-8 in patients with HIV infection","volume":"93","author":"Matsumoto","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"R52-27-20210226","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.1993.tb07957.x","article-title":"Elevated serum levels of IL-8 in patients with HIV infection","volume":"93","author":"Matsumoto","year":"1993","journal-title":"Clin Exp Immunol"},{"key":"R53-27-20210226","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1073\/pnas.0611670104","article-title":"A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients","volume":"104","author":"Vasilescu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R55-27-20210226","doi-asserted-by":"crossref","first-page":"35755","DOI":"10.1074\/jbc.M302889200","article-title":"Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes","volume":"278","author":"Balasubramanian","year":"2003","journal-title":"J Biol Chem"},{"key":"R56-27-20210226","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jlb.66.3.401","article-title":"Fully human anti-interleukin-8 monoclonal antibodies: potential therapeutics for the treatment of inflammatory disease states","volume":"66","author":"Yang","year":"1999","journal-title":"J Leukoc Biol"},{"key":"R57-27-20210226","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1097\/QAD.0b013e3283367836","article-title":"Plasma cytokine levels during acute HIV-1 infection predict HIV disease progression","volume":"24","author":"Roberts","year":"2010","journal-title":"AIDS Lond Engl"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000003734","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:10:02Z","timestamp":1786039802000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201605240-00027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":52,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000003734","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]}}}